Dis-Chem Pharmacies Limited announced revenue results for the year ended 28 February 2023. For year, the Group recorded revenue growth (excluding the contribution of COVID-19 vaccines and testing) of 9.0% compared to the corresponding financial period.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.62 ZAR | +0.99% | +2.16% | +9.55% |
02-23 | South Africa's Dis-Chem sales rise 12.2% on strong retail revenue | RE |
02-23 | Dis-Chem Pharmacies Limited Announces Group Revenue Results for the Period from 1 September 2023 to 28 January 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.55% | 1.55B | |
-22.12% | 12.04B | |
-24.76% | 6.52B | |
+15.41% | 6.44B | |
-9.27% | 6.15B | |
-2.48% | 4.63B | |
+60.00% | 4.62B | |
-6.67% | 3.93B | |
-10.60% | 3.49B | |
-6.69% | 3.05B |
- Stock Market
- Equities
- DCP Stock
- News Dis-Chem Pharmacies Limited
- Dis-Chem Pharmacies Limited Announces Revenue Results for the Year Ended 28 February 2023